There are many active research projects accessing and applying shared ADNI data. Use the search above to find specific research focuses on the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Susan Eaton |
| Institution: | Biogen |
| Department: | Global Analytics and Data Sciences |
| Country: | |
| Proposed Analysis: | Biogen has utilized the ADNI data in the past to improve the understanding of potential biomarkers for use to develop best clinical study entry criteria for compounds in development. In addition, we know that a sister team within Biogen, Biogen Digital Health, has obtained a copy of the ADNI files for use in exploring digitally derived biomarkers inclusive of the imaging files. Plans for this data include understanding the natural history of disease and specifically understanding how APOE genotype is associated with progression of the disease. |
| Additional Investigators | |
| Investigator's Name: | Cai Gillis |
| Proposed Analysis: | Biogen has utilized the ADNI data in the past to improve the understanding of potential biomarkers for use to develop best clinical study entry criteria for compounds in development. In addition, we know that a sister team within Biogen, Biogen Digital Health, has obtained a copy of the ADNI files for use in exploring digitally derived biomarkers inclusive of the imaging files. Plans for this data include understanding the natural history of disease and specifically understanding how APOE genotype is associated with progression of the disease. |
| Investigator's Name: | Jin Wang |
| Proposed Analysis: | Biogen has utilized the ADNI data in the past to improve the understanding of potential biomarkers for use to develop best clinical study entry criteria for compounds in development. In addition, we know that a sister team within Biogen, Biogen Digital Health, has obtained a copy of the ADNI files for use in exploring digitally derived biomarkers inclusive of the imaging files. Plans for this data include understanding the natural history of disease and specifically understanding how APOE genotype is associated with progression of the disease. |
| Investigator's Name: | Henry Kryzywy |
| Proposed Analysis: | Biogen has utilized the ADNI data in the past to improve the understanding of potential biomarkers for use to develop best clinical study entry criteria for compounds in development. In addition, we know that a sister team within Biogen, Biogen Digital Health, has obtained a copy of the ADNI files for use in exploring digitally derived biomarkers inclusive of the imaging files. Plans for this data include understanding the natural history of disease and specifically understanding how APOE genotype is associated with progression of the disease. |
